Frank J A, Girton M, Dwyer A J, Wright D C, Cohen P J, Doppman J L
Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892.
Radiology. 1988 Jun;167(3):825-9. doi: 10.1148/radiology.167.3.3363148.
Meningeal carcinomatosis developed in 14 of 14 New Zealand White rabbits after infusion of a VX2 tumor cell suspension into the cisterna magna. All died or were killed 7-15 days after inoculation. Within days of the tumor infusion, magnetic resonance (MR) imaging with gadolinium-diethylenetriaminepentaacetic acid (DTPA) at 0.5 or 1.5 T demonstrated enhancement of the cerebrospinal fluid (CSF) secondary to disruption of the blood-CSF barrier by plaquelike lesions along the meninges. Eventually, meningeal enhancement was observed along the base of the brain and cervical spine. Quantitative assessment of the contrast enhancement on T1-weighted images revealed an increase in mean signal intensity of 213% +/- 130%. Contrast enhancement was not observed in four control animals who received an infusion of cell culture medium. These results demonstrate in an animal model that contrast material-enhanced MR imaging can be used to detect meningeal carcinomatosis by revealing breakdown of the blood-CSF barrier.
将VX2肿瘤细胞悬液注入14只新西兰白兔的小脑延髓池后,所有14只兔子均发生了脑膜癌病。接种后7 - 15天内,所有兔子均死亡或被处死。在肿瘤注入后的数天内,使用0.5或1.5 T的钆 - 二乙烯三胺五乙酸(DTPA)进行磁共振(MR)成像显示,由于沿脑膜的斑块状病变破坏了血 - 脑脊液屏障,导致脑脊液(CSF)强化。最终,在脑底部和颈椎处观察到脑膜强化。对T1加权图像上的对比增强进行定量评估显示,平均信号强度增加了213%±130%。接受细胞培养基注入的4只对照动物未观察到对比增强。这些结果在动物模型中表明,对比剂增强的MR成像可通过揭示血 - 脑脊液屏障的破坏来检测脑膜癌病。